Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-10 to 2025-03-11
Current total value of award: $4630.4
Description: 4567519210!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML